Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
Sage Therapeutics Inc (NASDAQ: SAGE) closed the day trading at $7.17 down -1.78% from the previous closing price of $7.30. In other words, the price has decreased by -$1.78 from its previous closing price. On the day, 0.72 million shares were traded.
Ratios:
For a better understanding of SAGE, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.13 and its Current Ratio is at 9.13. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
On November 21, 2024, RBC Capital Mkts Upgraded its rating to Sector Perform which previously was Underperform but kept the price unchanged to $4.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 10 ’24 when JONAS JEFFREY M bought 7,500 shares for $5.53 per share.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 9.47 while its Price-to-Book (P/B) ratio in mrq is 1.09.
Stock Price History:
Over the past 52 weeks, SAGE has reached a high of $14.31, while it has fallen to a 52-week low of $4.62. The 50-Day Moving Average of the stock is -5.26%, while the 200-Day Moving Average is calculated to be -1.56%.
Shares Statistics:
A total of 62.54M shares are outstanding, with a floating share count of 55.09M. Insiders hold about 12.03% of the company’s shares, while institutions hold 80.66% stake in the company.
